CHWY

Chewy CFO, GC Trim Stakes After March Equity Grants

Two of Chewy's top officers sold stock on the open market within weeks of the company handing them fresh equity grants. General Counsel Da-wai Hu and CFO Christopher Deppe were the names on the Form 4s, and the timing — selling into the same window the company was loading up the C-suite with new shares — is the kind of choreography that gets noticed.

Chewy, Inc. (CHWY) — stock analysis
The numbers
  • GC Da-wai Hu sold 8,149 shares at $26.91 on April 1 for roughly $219,000 (Form 4).
  • CFO Christopher Deppe sold 3,043 shares at $26.87 on March 2 for roughly $82,000.
  • The company issued large equity awards on March 25 and April 8, including 394,868 shares to CEO Sumit Singh on April 8 and 526,284 shares on March 25.

What the Form 4s Actually Say

Insider activity over the trailing 90 days nets out to about $0.30M in open-market sales against zero purchases. That is a small number in absolute dollars, but the composition matters more than the size. Hu's $219,000 sale on April 1 and Deppe's $82,000 sale on March 2 were both genuine open-market dispositions, not the cashless tax-withholding mechanics that automatically clip a few percentage points off every vesting tranche.

Those tax-withholding dispositions also showed up. CEO Sumit Singh's largest single line item in the period was a 30,267-share withholding event on February 27 priced at $26.97, valued at roughly $816,000. That kind of disposition is mechanical — when restricted stock vests, shares get withheld to cover the tax bill — and reading it as a discretionary sale would overstate the case.

The Grant-Then-Sell Pattern

What sharpens the picture is the grant calendar. On March 25, Chewy filed an 8-K reporting earnings and issued equity awards including 526,284 shares to Singh, 49,962 to Hu, 14,470 to Chief Accounting Officer William Billings, and 4,342 to Deppe. Two weeks later, a separate 8-K on April 8 coincided with another tranche: 394,868 shares to Singh, 346,670 to Deppe, 37,486 to Hu, and 32,571 to Billings.

Deppe's 3,043-share sale predates both grants, so it is not a "took the grant, sold the grant" story for him. Hu's April 1 sale, by contrast, sits squarely between the two award dates. Neither sale is large enough on its own to constitute a signal — six-figure sales by named executive officers happen routinely under 10b5-1 plans. The point is directional: the people closest to the books are taking some chips off, not adding to them.

The Counter-Argument the Numbers Make

The bear read on insider behavior runs into a fundamentals problem. Chewy generated $453M in free cash flow on $12.6B of trailing revenue, a 29.8% gross margin, and a forward P/E of 12.9x. Earnings have come in ahead of consensus in each of the last three reported quarters: $0.35 versus $0.34, $0.33 versus $0.33, and $0.32 versus $0.30. That is not the cadence of a company missing the plot.

The street's $40.81 average price target against the current $25.42 print implies roughly 60% upside if analysts are right. Whether they are right is a different question — and one Chewy's modest 0.5% revenue growth makes harder to answer. A pet-retail business that grew at half a percent year over year is either reaching saturation or absorbing a customer-acquisition reset. The forward multiple suggests the market has priced in the cautious view.

What Comes Next

Chewy filed another 8-K on April 28 under Item 7.01 — a Regulation FD disclosure, which typically signals an investor event or selectively disclosed material that needs broadcasting. That filing is worth reading on its own terms. A separate MarketBeat report flagged the Teachers Retirement System of the State of Kentucky reducing its CHWY position, per filings two days old, which is a single data point but consistent with the soft-selling backdrop.

The neutral case here is straightforward. Free cash flow generation, consistent EPS beats, and a sub-13x forward multiple keep the floor from caving in. Insider selling by the GC and CFO, paired with anemic top-line growth, keeps a ceiling on enthusiasm. The next earnings release is the natural checkpoint — if revenue growth ticks back into the mid-single digits while margins hold, the analyst targets start looking less like a stretch. If growth stays at half a percent, the insiders' pacing will look prescient.

Run the free Chewy, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Are Chewy insiders selling stock?

Yes, on a small scale. Over the past 90 days, the General Counsel and CFO executed open-market sales totaling roughly $0.30M against zero purchases, as detailed in the filing analysis above.

Why did Chewy's CFO sell shares?

The Form 4 doesn't state a reason. The 3,043-share sale on March 2 followed equity grants, a common pattern for officers diversifying after vesting, as discussed in this report.

What is Chewy's analyst price target?

The average sell-side target is $40.81, against a current price of $25.42, implying material upside if the company executes on the fundamentals reviewed above.

Is Chewy stock cheap right now?

At a forward P/E of 12.9x with $453M in free cash flow, the multiple is undemanding, but trailing revenue growth of 0.5% complicates the bull case, as the analysis above explains.

When does Chewy report earnings next?

Chewy's most recent earnings 8-K was filed March 25, 2026. The next quarterly release is the catalyst that will test the neutral thesis laid out in this report.

Sources & filings